Suchergebnisse - "Rahman, Omar"

PubPharm (7)

1

Smoking and EGFR status may predict outcomes of advanced NSCLC treated with PD-(L)1 inhibitors beyond first line : A meta-analysis

enthalten in: The clinical respiratory journal | 2018

von Abdel-Rahman, O.

2

Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma : a systematic review

enthalten in: Immunotherapy | 2016

von Abdel-Rahman, O.

ErratumIn: Immunotherapy. 2017 Mar;9(4):373. - PMID 28303770

3

Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors : a meta-analysis

enthalten in: Therapeutic advances in respiratory disease | 2016

von Abdel-Rahman, O. | Fouad, M.

4

Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents : A meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2016

von Abdel-Rahman, O.

5

S-1-based regimens for locally advanced/metastatic non-small-cell lung cancer : a meta-analysis

enthalten in: Future oncology (London, England) | 2016

von Abdel-Rahman, O. | ElHalawani, H.

6

Risk of selected gastrointestinal toxicities in patients with advanced non-small cell lung cancer receiving erlotinib : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

7

Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors : a comparative meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | Elhalawani, H.

1
[1]